Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia

Clinical Cardiology

Volumn 23, Issue 3, 2000, Pages 171-174

  Rials, Seth J ^b   Britchkow, David ^b   Marinchak, Roger A ^b   Kowey, Peter R ^a  

^a Lankenau Medical Office Building East   (United States)

^b NONE

Author keywords

Conduction; Electrophysiologic study; Procainamide; Refractoriness; Ventricular tachycardia

Indexed keywords

PROCAINAMIDE;

ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; ELECTROGRAPHY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; PREDICTION; REFRACTORY PERIOD;

EID: 0034100256     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230308     Document Type: Article

References (18)

1. Fisher JD, Cohen HL, Mehra R, Altschuler H, Escher DJW, Furman S: Cardiac pacing and pacemakers. III. Serial electrophysiologic pharmacologic testing for control of recurrent tachyarrhythmias. Am Heart J 1977;93:658-668
2. Horowitz LN, Josephson ME, Kastor JA: Intracardiac electrophysiology studies as a method for the optimization of drug therapy in chronic ventricular arrhythmias. Prog Cardiovasc Dis 1980;23: 81-98
3. Mason JW, Winkle RA: Electrode catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 1978;58:971-985
4. Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL. Greenspan AM: Recurrent sustained ventricular tachycardia: Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 1978;58:986-997
5. Moss AJ, Hall WJ, Cannom DS, Daubert P, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940
6. Swiryn S, Bauernfeind RA, Strasberg B, Palileo E, Iverson N, Levy PS, Rosen KM: Prediction of response to class 1 antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia. Am Heart J 1982;104:43-50
7. Morady F, Hess D, Scheinman MM: Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: Importance of stimulation at more than one ventricular site. Am J Cardiol 1982;50:1055-1060
8. Marchlinski FE, Buxton AE, Vassallo JA, Waxman HL, Cassidy DM, Doherty JU, Josephson ME: Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias. J Am Coll Cardiol 1984;4: 1247-1254
9. Rae AP, Greenspan AM, Spielman SR, Sokoloff NM, Webb CR, Kay HR, Horowitz LN: Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies. Am J Cardiol 1985;55: 1494-1499
10. Waxman HL, Buxton AE, Sadowski LM, Josephson ME: The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. Circulation 1983;67:30-37
11. Oseran DS, Gang ES, Rosenthal ME, Mandel WJ, Peter T: Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: Value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment. Am J Cardiol 1985;56: 883-886
12. Interian A, Zaman L, Velez-Robinson E, Kozlovskis P, Castellanos A. Myerburg RJ: Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1991;17:1581-1586
13. Kowey PR, Friehling TD: Uses and limitations of electrophysiology studies for the selection of antiarrhythmic therapy. PACE 1986; 9:231-247
14. Greenspan AM, Horowitz LN, Spielman SR, Josephson ME: Large dose procainamide therapy for ventricular tachyarrhythmia. Am J Cardiol 1980;46:453-462
15. Torres V, Flowers D, Muira D: Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia. Am Heart 1984;108:1437-1442
16. Gold RL, Haffajee CI, Alpert JA: Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia. Am Heart J 1696;112:9-13
17. Kuchar DL, Rottman J, Berger E, Freeman CS, Garan H, Ruskin JN: Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study. JAm Coll Cardiol 1988;12:982-988
18. Colatsky TJ, Follmer CH, Starmer CF: Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 1990;82:2235-2242